Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Frizzled SMO receptor inhibitor LY-2940680 exhibits antitumor effects in vivo

April 11, 2011

Novel PLK4 inhibitors demonstrate antiproliferative activity in models of breast cancer

April 11, 2011

Marina Biotech advances phase Ib/IIa trial of CEQ-508 in FAP

April 8, 2011

First phase I trial begins for IMC-3C5 in advanced solid tumors

April 8, 2011

Chifcon Medicine R&D describes natural antitumor agents coupled to NO donors

April 8, 2011

Novartis discloses new inhibitors of cyclin-dependent kinase 9

April 8, 2011

Phase II results reported on T-DM1 in HER2-positive metastatic breast cancer

April 8, 2011

DSP and BBI sign option license agreement for anticancer drug

April 8, 2011

OBT to use BioWa's Potelligent technology for cancer programs

April 8, 2011

SuperGen and Astex Therapeutics enter merger agreement

April 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...